Cargando…
Current Research and Development of Chemotherapeutic Agents for Melanoma
Cutaneous malignant melanoma is the most lethal form of skin cancer and an increasingly common disease worldwide. It remains one of the most treatment-refractory malignancies. The current treatment options for patients with metastatic melanoma are limited and in most cases non-curative. This review...
Autores principales: | Hsan, Kyaw Minn, Chen, Chun-Chieh, Shyur, Lie-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835084/ https://www.ncbi.nlm.nih.gov/pubmed/24281076 http://dx.doi.org/10.3390/cancers2020397 |
Ejemplares similares
-
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment
por: Wu, Tai-Na, et al.
Publicado: (2021) -
Cumingianoside A, a Phyto-Triterpenoid Saponin Inhibits Acquired BRAF Inhibitor Resistant Melanoma Growth via Programmed Cell Death
por: Cvetanova, Biljana, et al.
Publicado: (2019) -
Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949) -
Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021) -
Phytogalactolipid dLGG Inhibits Mouse Melanoma Brain Metastasis through Regulating Oxylipin Activity and Re-Programming Macrophage Polarity in the Tumor Microenvironment
por: Yang, Chung-Chih, et al.
Publicado: (2021)